Association between Triglycerides and Residual Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] trial)

Triglyceride (TG) levels encompass several lipoproteins that have been implicated in atherogenic pathways. Whether TG levels independently associate with cardiovascular disease both overall and, in particular among patients with established coronary artery disease (CAD) and type 2 diabetes (T2DM), remains controversial. Data from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial was used to evaluate patients with T2DM and CAD. Cox proportional hazards models were used to determine the association between TG levels and outcomes.

Source: The American Journal of Cardiology - July 10, 2020 Category: Cardiology Authors: Adam J Nelson, Ann Marie Navar, Hillary Mulder, Daniel Wojdyla, Sephy Philip, Craig Granowitz, Eric D Peterson, Neha J Pagidipati Source Type: research